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Abstract We bad previously identified an estrogen responsive 
protein ULF-250, synthesized and secreted by the estrous rat 
uterus, which is immunologically distinct from complement C3 
and az-macroglobulin. The N-terminal microsequencing of ULF- 
250 followed by sequence homology analysis showed that this 
protein is a new member of a class of estrogen responsive proteins 
in the uterus. Polymerase chain reaction with a ULF-250 specific 
primer yielded partial sequence information of its message. The 
observed pattern of ULF-250 message in the uterus during the 
various stages of the reproductive cycle in the rat suggested a 
possible regulation of ULF-250 message by 17gestradiol. 
Upstream sequencing of ULF-250 message and its promoter 
domains would provide insight into the mechanism of its 
regulation by estradiol. 
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1. Introduction 
The mammalian uterus is an organ which responds pro- 
foundly to sex steroids such as estrogen and progesterone. 
Estrogen and progesterone influence uterine functions in 
both independent and interdependent fashion. Estrogen is a 
potent mitogen for the uterus of adult mammals [l]. The 
mitogenic effect of estrogen involves the regulation of the 
expression of genes such as c-fos, c-myc, c-jun and jun-B, 
whose products control the cell cycle, and is mediated by an 
estrogen receptor which can modulate gene expression by 
binding with estrogen response element (ERE) localized in 
the proximity of the target genes [2-4]. Induction of c-fos 
gene by 17P-estradiol was observed in the rat uterus [5,6], 
specially in the luminal and glandular epithelia [7]. Other pro- 
teins expressed in the uterus and secreted into the lumen un- 
der hormonal influence include the presumptive induced pro- 
tein [8], alpha uterine protein (AUP) [9,10], the estrogen 
responsive induced protein (IP) Ill], which was later shown 
to be a creatine kinase [12], a cat uterine protein that is estro- 
gen dependent (CUPED), which was localized in the endome- 
trial epithelial cells [13], and a mouse lactotransferrin [14]. In 
addition, estradiol regulates the expression of growth arrest 
specific (gas) genes [15,16], growth factors and their receptors 
[17,18]. Estradiol administered to immature rats stimulated 
the synthesis and secretion of proteins by the uterus [19-211. 
These proteins include complement C3 and immunoglobulin 
[22,23]. 
Uterine luminal fluid (ULF) of the mammal constitutes the 
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immediate environment for early reproductive events and is 
thus an important factor in successful fertilization and subse- 
quent implantation of the embryo [24]. In addition, ULF 
proteins are reported to play significant roles in fetal growth 
and development [25,26] as well as in the facilitation of ma- 
ternal/fetal interactions [27-291. ULF contains a complex ar- 
ray of molecules, including secretory proteins of both endo- 
metrial and plasma origin [25,30]. Steroid hormones such as 
estrogen and progesterone are reported to modulate the 
synthesis of uterine proteins [20,25,31-361, the uptake and 
transport of certain serum proteins by the uterus [37], and 
the movement of specific plasma components across the en- 
dometrium into the uterine lumen [38]. 
Our laboratory has recently identified an estrogen respon- 
sive protein (ESP) with an estimated molecular weight of 260 
kDa (corrected later as 250 kDa), synthesized and secreted by 
the estrous rat uterus [39], which is immunologically distinct 
from complement C3 and az-macroglobulin [40], as demon- 
strated by Western blot analysis. It was also shown that the 
production of ULF-250 is regulated by estradiol and that this 
protein is not a component of blood plasma. The biological 
significance of this protein and the mechanism through which 
estradiol regulates the synthesis and/or secretion of this pro- 
tein are not known. In the present study, we attempted to 
further understand the ULF-250 through protein microse- 
quencing and to partially characterize the message encoding 
this protein employing a reverse-transcriptase polymerase 
chain reaction. 
2. Materials and methods 
2.1. Chemicals 
Dulbecco’s modified Eagle’s medium (D-MEM) was purchased 
from Life Technologies. 17P-Estradiol and the antibiotics were from 
Sigma Chemical Company. HiTrap Blue column, QuickPrep mRNA 
purification kit, Ready-to-Go T-primed first strand synthesis kit and 
Sephaglass BandPrep kit were from Pharmacia Biotech. BCA protein 
assay kit (Pierce), Centriprep-10 and Centricon- (Amicon) were 
also procured. All reagents for protein electrophoresis were from 
BioRad. NuSieve 3 : 1 Agarose was obtained from FMN Biochemicals. 
2.2. Animals 
Young adult female rats (Sprague-Dawley) were obtained from 
Charles River (Wilmington, MA). Vaginal smears were examined to 
identify the estrus phase of the animals. The estrus phase animals were 
killed by CO2 asphyxiation. The abdomen was opened, the uterine 
horns were exposed and the uterine luminal fluids were collected using 
a 5 ml syringe fitted with a 23 gauge needle. The fluids from different 
animals were pooled and were frozen immediately at -20°C. The 
uterine horns were dissected out, cleaned of fat and connective tissue, 
slit longitudinally and rinsed three times in D-MEM supplemented 
with 1 @ml streptomycin and 100 hg/ml penicillin. The tissues 
were incubated in 3 ml of D-MEM for 6 h at 37°C in a 95% air- 
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5% COa atmosphere with occasional agitation. After incubation, the 
tissues were removed and the medium centrifuged. The supernatant 
was processed as described below. 
2.3. Afi-gel blue chromatography 
Affi-gel blue chromatography was performed according to the in- 
structions of the manufacturer (Pharmacia), for the removal of albu- 
min. HiTrap Blue 5 ml columns were equilibrated with buffer A (50 
mM KHzPOd, pH 7.0) at room temperature. The sample was loaded 
onto the column with a syringe. The eluted albumin-free fraction was 
concentrated in an Amicon Centriprep-10 concentrator. 
2.4. Protein analysis 
The protein concentrations of the ULF and the albumin-free super- 
natant were determined by the bicinchoninic method of Smith et al. 
[41]. The final concentration of the protein in the sample was adjusted 
to 5 mg/ml. An aliquot of the sample was denatured in Laemmli 
sample buffer. Approximately 50 pg protein/well was loaded onto a 
discontinuous gradient gel (4% stacking, 8-15% linear gradient separ- 
ating) and electrophoresis was performed at 100 V for 3 h on a 
MiniProtean minigel format (BioRad). After electrophoresis, the sep- 
arated proteins were electroblotted onto a 0.2 nm PVDF membrane 
using CAPS transfer buffer (10 mM CAPS+lO% methanol, pH 11 .O) 
at 30 mA for 3 h. After the transfer was completed, the membrane 
was stained with 0.01% amido black in 40% methanol/IO% acetic acid 
for 5 min and destained l-3 times with 40% methanol/lo% acetic acid 
(5 min each. followed bv several washes with ddH70). The 250 kDa 
bands from ‘10 lanes were cut out and were processed for N-terminal 
protein sequence analysis based on Edman chemistry followed by 
PTH analysis using microbore HPLC (HP G-1000A equipped with 
a 1090 PTH analyzer) [42]. The protein sequence data were obtained 
at the Rockefeller University Protein/DNA Technology Center. 
2.5. RT-PCR of the 250 kDa protein message 
mRNA from diestrous, proestrous and estrous uteri were extracted 
using QuickPrep mRNA purification kit (Pharmacia) following the 
instructions of the manufacturer. The mRNA concentration was ad- 
justed to 50 kg/ml and the preparations were immediately processed 
for first strand synthesis. The first strand synthesis was performed 
with 2 pg of mRNA, using a Ready-To-Go T-primed first strand 
synthesis kit (Pharmacia) which utilizes Moloney murine leukemia 
virus (M-MuLV) reverse transcriptase and Notl-d(T)is primer (5’- 
d[AACTGGAAGAATTCGCGGCCGCAGGAAT&3’). PCR of 
the first strand was performed using a gene-specific sense primer 
(GSP-250) designed from the reverse-translated N-terminal sequence 
of ULF-250, Notl-d(T)is reverse primer and other reagents from 
GeneAmp PCR Reagent kit with AmpliTaq DNA polymerase (Perkin 
Elmer). PCR was carried out on a Perkin-Elmer Cetus 480 thermo- 
cycler. The cycling conditions were: 1 min melting at 94°C 45 s 
annealing at 68°C and 1 min primer extension at 72°C. The cycle 
was repeated 35 times, with 10 s increments in extension time per 
cycle. After the completion of the cycles, the reaction was held at 
72°C for 30 min, after which the samples were recovered. 
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Fig. 1. A: The N-terminal amino acid sequence of the uterine lumi- 
nal fluid protein ULF-250. B: BLASTP alignment of the N-terminal 
sequence of ULF-250 with hypothetical gene 45 protein (accession 
number QOOl 11). 
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Fig. 2. Agarose gel electrophoresis of the PCR product obtained by 
amplifying the mRNA preparations from the uteri of rats in various 
stages of their reproductive cycle. Lanes are as follows: 100 bp lad- 
der (1) and PCR products from diestrous (2) proestrous (3) and es- 
trous (4) rats. Lane 5 shows a 500 bp hDNA. Lane 6 shows a nega- 
tive control. Arrow points towards a 450 bp band, which appeared 
in proestrus and estrus stage uteri. 
2.6. Agarose electrophoresis 
5 pl from each of the reactions was mixed with 1 pl of 6~ gel 
loading buffer (Sigma) and was separated on 4% Nu-Sieve 3: 1 agarose 
(FMN) gel and 1 x TAE buffer. Electrophoresis was performed at 5 VI 
cm2 for 3 h. The gels were visualized and photographed on a UV 
transilluminator. The band of interest was sliced off and the DNA was 
recovered using Sephaglass BP BandPrep kit (Pharmacia). The pur- 
ified band was subjected to dyedeoxy chain termination sequencing on 
an ALF sequencer (ABI Prism, Applied Biosystems). 
3. Results 
3.1. Protein microsequencing 
The N-terminal microsequencing of ULF-250 from both 
uterine luminal fluid and the culture medium produced essen- 
tially the same N-terminal sequence. The obtained sequence is 
shown in Fig. 1A. This sequence was subjected to a BLASTP 
search [43] using the National Center for Biotechnology In- 
formation WWW server, followed by a BEAUTY post-proc- 
essing [44] provided by the Human Genome Center, Baylor 
College of Medicine. It was found that our sequence showed 
66% identity with a hypothetical gene 45 protein from herpes- 
virus 1 (strain auburn 1) (Genbank accession number. 
QOOl 11). However, this homology is statistically insignificant. 
A MACAW alignment of these two sequences is shown in 
Fig. 1B. 
3.2. PCR ampltjication of ULF-250 message 
We exploited the available N-terminal protein sequence of 
ULF-250 to design a gene-specific primer. The N-terminal 
amino acid sequence was reverse translated using a GCG 
Backtranslate option and the rat codon usage. This compu- 
ter-simulated 5’ message was used to design a sense primer 
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1 gacctcctac atatgaacca ttttcattct gtgcagtgca gggattgaac tctgagcctc 
61 atgcatgcta gataagtact ggctgtatct ctagccctga tttttttctt tttagagaaa 
121 ttgtgaaaat acttataaac atactgaaag tcactttaaa attctggaat tacatgattc 
181 accttgtatg attaataaac aatactattc tgtgaaaaaa aaaaaaaaaa aaaacccggg 
241 ggnggggggg gqgcggtttt 
A 
35 
ULF-250 
ZK-666 
CENP-A 
B 
Fig. 3. A: Nucleotide sequence obtained from the 450 bp PCR fragment from the estrus stage uteri. B: A MACAW alignment of the obtained 
sequence with its homologues ZK666 and CENP-A obtained from the database. 
using the Xprimer software at ExPaSy. A 27-mer primer 
(GSP-250) was thus designed (5’-GAATTCTCATCAAGCC- 
CATGATGATTC-3”) and was used as the sense primer. 
Notl-d(T)is was used as the reverse primer. We could obtain 
a clear 450 bp band in samples from the estrus stage uterus. 
This band was absent in diestrous uterine preparations. A 
weak signal at the 450 bp position was observed in proestrous 
uterine samples (Fig. 2). 
A dye-termination cycle sequencing of this 450 bp band 
with the GSP-250 primer produced a sequence as shown in 
Fig. 3A. This sequence showed statistically significant partial 
homology with Caenorhabditis elegans cosmid ZK666 se- 
quence (gi790416) and human centromere protein-A (CENP- 
A) mRNA (gi602413). A MACAW aligned image of these 
sequences is provided (Fig. 3B). The nucleotide sequence (ac- 
cession number RNU 53183) and the predicted amino acid 
sequence (accession number g1279988) of ULF-250 have 
been submitted to the Genbank. 
4. Discussion 
In the present study, we have microsequenced the N-termi- 
nus of ULF-250 from estrous rat uterine luminal fluid and the 
culture medium. The identity in the sequence implies that the 
two proteins are essentially the same. Earlier reports on ULF- 
250 (previously called ESP-260) had shown that ULF-250 
could be induced by Ez [39] and that antiestrogens could 
block the estradiol-mediated ULF-250 induction [39,40]. Be- 
cause complement Cs and as-macroglobulin are present in the 
uterine luminal fluid and both of them migrate to a -200 
kDa region, it was necessary to check the possibility that 
ULF-250 could be one of these proteins. In a recent paper 
from our lab, we could show on immunoblots that ULF-250 
was not recognized by anti-complement Ca or the anti-a2- 
macroglobulin antibodies suggesting that it is not possibly 
one of these components [40]. Since a BLASTP analysis of 
the N-terminal amino acid sequence of ULF-250 protein did 
not show any significantly similar member in the database, it 
is reasonable to feel that we have identified a novel estrogen- 
induced uterine luminal protein. 
The polymerase chain reaction targeting the ULF-250 mes- 
sage at various stages of the reproductive cycle in the rat 
showed that this message was absent in the diestrous uteri. 
A weak ULF-250 message was detectable in proestrous uteri, 
which became prominent in estrous uteri (Fig. 2). This obser- 
vation is in perfect agreement with the ULF-250 protein pro- 
files reported earlier [39]. The nucleotide sequence data ob- 
tained from this amplified message (Fig. 3) showed that we 
have captured the 3’ end of a relatively big ULF-250 message. 
Moreover, the appearance of a 450 bp band in PCR implies 
that the ULF-250 message contains at least one internal re- 
peat of its N-terminal motif. 
The pattern of the appearance of the ULF-250 message in 
the rat uterus follows the natural 17gestradiol profiles in the 
serum of cycling female rats, suggesting a regulation of ULF- 
250 message by this steroid hormone. 17B-Estradiol has been 
shown to regulate the expression of a variety of genes, includ- 
ing G6PD [45], TNF-a [46], Raf-1 [47], cystic fibrosis trans- 
membrane regulator (CFTR) [48], lactoferrin [24], c-&n [49], 
srp27 [50], by modulating mRNA synthesis, mRNA transla- 
tion, protein processing and protein stability. The normal 
route through which estradiol regulates gene expression in 
target organs starts with the activation of a transcription fac- 
tor (ER) which in turn binds a specific hormone response 
element (ERE) which is a perfect palindrome with the se- 
quence GGTCAnnnTGACC [5 11. 
Thus, we would conclude that ULF-250 is a novel estrous 
cycle specific gene product. A complete molecular, structural 
and functional characterization of this novel estrogen induci- 
ble gene family member could resolve its possible involvement 
in contributing to female fertility regulation. 
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